Eli Lilly Trims Price of Popular Weight-Loss Drug on Its Site a Month After Trump Deal

Shelby Knowles / Bloomberg / Getty Images Close Key Takeaways Eli Lilly (LLY) said Monday that it's lowering the price of its popular weight-loss drug Zepbound, about a month after striking a deal with the Trump administration to lower drug costs. The company said the price for a once-a-month single vial purchased through its LillyDirect digital health care platform will go down $50 for the 2.5-, 7.5-, 10-, 12.5-, and 15-milligram doses, and $100 for the 5-milligram dose. The prices range from $299 for the ...